Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
3,399,038
-
Share change
-
-374,998
-
Total reported value
-
$522,621,545
-
Price per share
-
$153.77
-
Number of holders
-
240
-
Value change
-
-$58,318,680
-
Number of buys
-
75
-
Number of sells
-
123
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q1 2024
As of 31 Mar 2024,
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) was held by
240 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,399,038 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, LPL Financial LLC, UBS Group AG, Royal Bank of Canada, Berger Financial Group, Inc, Raymond James Financial Services Advisors, Inc., RAYMOND JAMES & ASSOCIATES, OSAIC HOLDINGS, INC., and COMMONWEALTH EQUITY SERVICES, LLC.
This page lists
240
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.